AR029283A1 - Proceso para la preparacion de derivados de la quinolina - Google Patents

Proceso para la preparacion de derivados de la quinolina

Info

Publication number
AR029283A1
AR029283A1 ARP010103033A ARP010103033A AR029283A1 AR 029283 A1 AR029283 A1 AR 029283A1 AR P010103033 A ARP010103033 A AR P010103033A AR P010103033 A ARP010103033 A AR P010103033A AR 029283 A1 AR029283 A1 AR 029283A1
Authority
AR
Argentina
Prior art keywords
formula
compound
amount
added
reacted
Prior art date
Application number
ARP010103033A
Other languages
English (en)
Original Assignee
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syngenta Participations Ag filed Critical Syngenta Participations Ag
Publication of AR029283A1 publication Critical patent/AR029283A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • C07D215/28Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Los compuestos de la formula (1) en la cual R1 es hidrogeno o cloro, y R2 es hidrogeno, C1-8 alquilo o C1-8 alquilo sustituido por C1-6 alcoxi o por C3-6 alqueniloxi, pueden ser preparados como sigue: a) se introduce la porcion principal de la cantidad a ser hecha reaccionar de un compuesto de la formula (2) en una mezcla de solventes que comprende por lo menos un solvente orgánico capaz de formar un azeotropo con agua, y por lo menos un solvente aprotico bipolar; b) se agrega en forma dosificada una base acuosa fuerte en una cantidad equivalente a dicha porcion principal de la cantidad total del compuesto de la formula (2); c) se adiciona la porcion restante de la cantidad a ser hecha a reaccionar, al compuesto de la formula (2); d) se adiciona una base débil en una cantidad que es por lo menos equivalente a dicha porcion restante; e) se retira el agua de la mezcla reactiva, mediante destilacion azeotropica; f) se adiciona un compuesto de la formula (3), en el cual R2 es como se define para la formula (3) en la cual R2 es como se define para la formula (1); y g) se aísla el compuesto resultante de la formula (1) de la mezcla reactiva.
ARP010103033A 2000-06-28 2001-06-26 Proceso para la preparacion de derivados de la quinolina AR029283A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH12742000 2000-06-28

Publications (1)

Publication Number Publication Date
AR029283A1 true AR029283A1 (es) 2003-06-18

Family

ID=4565202

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103033A AR029283A1 (es) 2000-06-28 2001-06-26 Proceso para la preparacion de derivados de la quinolina

Country Status (23)

Country Link
US (1) US6660865B2 (es)
EP (1) EP1294694B1 (es)
JP (1) JP3955814B2 (es)
KR (1) KR100572818B1 (es)
CN (1) CN1256327C (es)
AR (1) AR029283A1 (es)
AT (1) ATE280760T1 (es)
AU (1) AU780534B2 (es)
BR (2) BR0112064B1 (es)
CA (1) CA2412543C (es)
DE (1) DE60106760T2 (es)
DK (1) DK1294694T3 (es)
ES (1) ES2228923T3 (es)
HU (1) HU230214B1 (es)
IL (2) IL153424A0 (es)
MX (1) MXPA02012398A (es)
PL (1) PL200447B1 (es)
PT (1) PT1294694E (es)
RU (1) RU2263110C2 (es)
TW (1) TWI230154B (es)
UA (1) UA73587C2 (es)
WO (1) WO2002000625A2 (es)
ZA (1) ZA200300328B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2350012B1 (en) * 2008-10-06 2017-06-28 The Johns Hopkins University Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
CN101805288A (zh) * 2010-04-21 2010-08-18 新沂市永诚化工有限公司 一种合成解毒喹的新方法
GB201119690D0 (en) * 2011-11-14 2011-12-28 Syngenta Participations Ag Process for the preparation of compounds
CN102718706B (zh) * 2012-05-31 2014-05-07 绍兴文理学院 一种2-(5-氯-8-喹啉氧基)乙酸的制备方法
CN103524411B (zh) * 2013-10-21 2015-03-04 哈尔滨理工大学 一种5-氯-8-喹啉氧基乙酸的合成方法
CN105001158B (zh) * 2015-07-09 2018-02-02 北京颖泰嘉和生物科技股份有限公司 一种合成解草酯的方法
CN113135851A (zh) * 2021-04-26 2021-07-20 甘肃联凯生物科技有限公司 一种解毒喹的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094349B1 (de) * 1982-05-07 1994-04-06 Ciba-Geigy Ag Verwendung von Chinolinderivaten zum Schützen von Kulturpflanzen
EP0492366B1 (de) * 1990-12-21 1997-03-26 Hoechst Schering AgrEvo GmbH Neue 5-Chlorchinolin-8-oxyalkancarbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antidots von Herbiziden

Also Published As

Publication number Publication date
IL153424A0 (en) 2003-07-06
CN1568314A (zh) 2005-01-19
US6660865B2 (en) 2003-12-09
DE60106760T2 (de) 2005-11-03
WO2002000625A3 (en) 2002-07-18
PL363224A1 (en) 2004-11-15
AU780534B2 (en) 2005-03-24
PL200447B1 (pl) 2009-01-30
ATE280760T1 (de) 2004-11-15
EP1294694A2 (en) 2003-03-26
US20030181724A1 (en) 2003-09-25
WO2002000625A2 (en) 2002-01-03
KR100572818B1 (ko) 2006-04-25
HUP0300703A3 (en) 2005-01-28
EP1294694B1 (en) 2004-10-27
BRPI0112064B8 (pt) 2018-08-14
HU230214B1 (hu) 2015-10-28
HUP0300703A2 (hu) 2003-07-28
ZA200300328B (en) 2004-03-31
BR0112064A (pt) 2003-05-13
IL153424A (en) 2007-08-19
JP3955814B2 (ja) 2007-08-08
TWI230154B (en) 2005-04-01
PT1294694E (pt) 2005-02-28
CA2412543C (en) 2010-05-25
CN1256327C (zh) 2006-05-17
RU2263110C2 (ru) 2005-10-27
DE60106760D1 (de) 2004-12-02
ES2228923T3 (es) 2005-04-16
JP2004501898A (ja) 2004-01-22
MXPA02012398A (es) 2003-04-25
DK1294694T3 (da) 2004-12-27
UA73587C2 (en) 2005-08-15
BR0112064B1 (pt) 2012-12-25
AU7968901A (en) 2002-01-08
KR20030036245A (ko) 2003-05-09
CA2412543A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
AR100291A2 (es) Composición catártica
PE20050222A1 (es) Compuestos de triazol como antagonistas de vasopresina
UY37399A (es) Proceso químico para la elaboración de determinados derivados de pirimidina
CO6310992A2 (es) Metodo para preparar chalconas de 3-trifluorometilo
AR051373A1 (es) Procedimiento para la preparacion de analogos aciclicos de nucleotidos de fosfonatos
PE20030612A1 (es) Benzoimidazoles
EA200300391A1 (ru) Имидазольные соединения, арил- или гетероарилконденсированные, в качестве противовоспалительных и анальгетических средств
PE20020179A1 (es) DERIVADOS DE (6S,9R,10S,11S,13S,16R, 17R)-9-CLORO-6-FLUORO-11-HIDROXI-10,13,16-TRIMETIL-3-OXO-6,7,8,9,10,11,12,13,14,15,16,17-DODECAHIDRO-3H-CICLOPENTA[a]FENANTRENO CARBOXILICO
MA38865A1 (fr) Formulation comprenant un agent hypolipidémiant
PE20080131A1 (es) Agentes antifungicos
PE20050012A1 (es) Compuestos de benzopirano como inhibidores de la ciclooxigenasa-2
AR029283A1 (es) Proceso para la preparacion de derivados de la quinolina
JP2005534778A5 (es)
GB963639A (en) New piperidine derivatives and processes for preparing the same
AR036000A1 (es) Proceso para la preparacion de derivados de indol y novedosos intermediarios
Walling et al. . delta.-Chloro alcohols and tetrahydrofurans from primary and secondary alkyl hypochlorites
AR037521A1 (es) Derivados de piperazina que tienen actividad antagonista del sst1, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de la depresion, ansiedad y padecimientos bipolares y una combinacion
JPS6234026B2 (es)
EA199700030A2 (ru) Новые производные 2,3-бензодиазепина
AR028740A1 (es) Procedimiento para la preparacion de pirazolopirimidinonas
AR043037A1 (es) Benzo [1,2,5] tiadiazoles y su uso farmaceutico
RU2003100505A (ru) Способ получения производных хинолина
UY26388A1 (es) Procedimiento para la preparacion de compuestos de pirazolo (4,3-d) pirimidin - 7-onas-3- piridilsulfonilo e intermedios de los mismos.
CO4980899A1 (es) Proceso para la sintesis de los compuestos intermediarios de cloropurina
AR030373A1 (es) Profarmacos para el tratamiento de enfermedades relacionadas con el receptor del nmda

Legal Events

Date Code Title Description
FG Grant, registration